Adrafinil (Olmifon) is part of a family of drugs called “eugeroics”, which means “good arousal”. It gently stimulates the central nervous system that is used to relieve excessive day time sleepiness and lack of concentration and attention in elderly patients. It promotes vigilance and alertness by enhancing the chemical processes within the brain without affecting heart rate or pressure, and does not affect normal sleep patterns.
How Does It Work?
Adrafinil (Olmifon) was discovered in the late 1970s in association with the French pharmaceutical company Group Lafon. The drug was first used as an experimental treatment for narcolepsy in France in 1986 and has since been approved in many European countries for treating this condition.
Compared with other familiar stimulants, such as caffeine or methamphetamine, Adrafinil (Olmifon) is gentler as it does not precipitate the anxiety, agitation and insomnia associated with these conventional stimulants. Of particular interest is its unique ability to only arouse when stimulation is required.
Adrafinil (Olmifon) builds slowly over a period of days and months, due to its action of selectively stimulating adrenergic brain receptors. These receptors normally respond to norepinephrine (noradrenaline), a neurotransmitter that is linked to alertness, learning, and memory. In contrast, conventional stimulants access a broader spectrum of brain receptors, including those involving dopamine.
Other Benefits
Adrafinil (Olmifon) is also beneficial in helping non-narcoleptic users. It is found to increase energy and reduce fatigue, while positively affecting cognitive function, mental clarity, concentration and general memory. It has been reported that, following use, quiet people become more talkative, reserved people tend to become more open, and passive people become more active.
source: www.antiaging-systems.com
